Back to discover
Disease
Fractures, Open
Late-stage therapeutic developmentEmerging research
1
Publications
6
Clinical trials
2023
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2023-09-08Frontiers in immunology
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 2 clinical trials with recent milestones (1 completed or reporting results).
Major developments
Major trial resultsHigh impact
Results posted2026-03-06
Major clinical milestoneHigh impact
Primary completion2026-07-01
Clinical MilestonesViewHide
Results posted
- 2026-03-06Acute Application Of Intrawound Antibiotic Powder In Open Extremity Fracture WoundsResults posted
Recently completed
- 2026-07-01Does Prophylactic Local Tobramycin Injection Lower Open Fracture Infection Rates?Primary completion
Activity timeline2
- 2026-07-01ClinicalDoes Prophylactic Local Tobramycin Injection Lower Open Fracture Infection Rates?Primary completion
- 2026-03-06ClinicalAcute Application Of Intrawound Antibiotic Powder In Open Extremity Fracture WoundsResults posted
Clinical trials
The current development programme across all trial phases.
Clinical programme
6
1
4
1
Late-stage studies
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Fractures, Open1
- Methicillin-Resistant Staphylococcus aureus1
- Osteomyelitis1
- Staphylococcal Infections1
Leading journals1
- Frontiers in immunology1
Leading researchers7
- Chen Y1
- Fu Y1
- Lin Z1
- Liu G1
- Liu Z1
- Lu M1
- Yu B1
Affiliations (unnormalised)3
- Guangdong Provincial Key Laboratory of Bone and Cartilage Regenerative Medicine1
- Southern Medical University Nanfang Hospital1
- Trauma Center1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Fractures in which there is an external wound communicating with the break of the bone.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.